| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.08▲ | 1.08▲ | 1.08▲ | 1.09▲ | 1.05▲ |
| MA10 | 1.05▲ | 1.05▲ | 1.05▲ | 1.06▲ | 1.16▼ |
| MA20 | 1.05▲ | 1.05▲ | 1.04▲ | 1.05▲ | 1.31▼ |
| MA50 | 1.04▲ | 1.08▲ | 1.10▲ | 1.20▼ | 1.82▼ |
| MA100 | 1.11▲ | 1.16▼ | 1.18▼ | 1.35▼ | 1.97▼ |
| MA200 | 1.19▼ | 1.28▼ | 1.31▼ | 1.72▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.012▲ | 0.014▲ | 0.019▲ | -0.004▼ |
| RSI | 76.634▲ | 66.879▲ | 62.578▲ | 51.837▲ | 37.937▼ |
| STOCH | 64.444 | 58.889 | 58.889 | 69.091 | 14.879▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -15.000▲ | -75.714▼ |
| CCI | 202.289▲ | 201.637▲ | 200.717▲ | 134.367▲ | -64.736 |
|
Wednesday, October 14, 2026 01:18 PM
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® ...
|
|
Thursday, September 03, 2026 07:54 AM
ImmunityBio looks attractive due to ANKTIVA's FDA approval for BCG-unresponsive NMIBC and pipeline expansion potential. See why I rate IBRX stock a Buy.
|
|
Sunday, June 07, 2026 05:00 PM
Agilent Technologies Inc. (NYSE: A) announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company’s products, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/10/26 | 1.12 | 1.12 | 1.12 | 1.12 | 433 |
| 26/10/26 | 1.07 | 1.139 | 1.06 | 1.09 | 5,860 |
| 23/10/26 | 1.0923 | 1.15 | 1.0415 | 1.065 | 5,838 |
| 22/10/26 | 1.12 | 1.12 | 1.07 | 1.09 | 5,729 |
| 21/10/26 | 1.12 | 1.13 | 1.08 | 1.08 | 10,966 |
| 20/10/26 | 1.03 | 1.08 | 1.03 | 1.08 | 3,248 |
| 19/10/26 | 1.02 | 1.065 | 1.02 | 1.04 | 39,689 |
| 16/10/26 | 1.0301 | 1.0301 | 1.02 | 1.02 | 5,409 |
| 15/10/26 | 1.015 | 1.035 | 1.015 | 1.03 | 4,503 |
| 14/10/26 | 1.00 | 1.02 | 0.9977 | 1.00 | 26,811 |
|
|
||||
|
|
||||
|
|